Mopec Group Announces Strategic Consolidation of Operations to Michigan Headquarters

Mopec Group Consolidates Operations to Michigan



MADISON HEIGHTS, Mich., Aug. 14, 2025 – Mopec Group, recognized for its top-notch anatomic and forensic pathology equipment, has declared a strategic shift in operations. The company will be merging its Californian facilities into its main headquarters located in Madison Heights, Michigan. This significant change comes after a multi-year initiative aimed at streamlining their product offerings and optimizing operational efficiency, allowing Mopec to better address increasing customer demands.

In a statement, Francis X. Dirksmeier, the CEO of Mopec Group, expressed, “This move reflects the progress we've made to serve our customers and build the platform for the treatment of disease.” He emphasized that this shift includes investments in personnel, such as hiring additional manufacturing staff, enhancing production systems, and adopting capital investments in automation. This strategic consolidation ensures that Mopec is ready to centralize its operations, ultimately allowing for scalable growth from its Michigan facility.

Mopec Group aims to enrich lives through innovative solutions in pathology, ensuring that the company can meet future medical requirements. Michigan Governor Gretchen Whitmer welcomed the news, noting, “We are excited to have Mopec Group’s diversified operations in Michigan. Their presence will tap into our skilled workforce and further boost our economy, while creating well-paying jobs.” This partnership underscores Michigan's commitment to fostering innovation and enhancing industry capabilities within the state.

In collaboration with the Michigan Economic Development Corporation (MEDC), Mopec is set to execute a broader growth strategy that includes workforce training, recruitment, and operational investments. This alignment not only reflects the ideal timing for Mopec’s expansion due to increased demand but also a fine-tuning of product lines and production capacity, contributing to the company's long-term success.

MEDC CEO Quentin Messer, Jr. expressed enthusiasm about this alliance, stating, “Our culture of innovation and dedication to excellence is foundational to our identity in Michigan, making us proud partners with Mopec Group as they expand their impact here.” He further mentioned that the partnership with Mopec is the start of a commitment to ensuring that everyone understands they can succeed in Michigan.

Within this transition, the Mortech brand will continue as Mopec Group's primary forensic line, maintaining its legacy and influence in specialized environments. Dirksmeier noted, “We thank our California team for their dedication, and this change allows us to operate more efficiently while continuing to invest in comprehensive solutions our clients rely on.”

Founded in 1992 and headquartered in Madison Heights, Mopec Group is not only a supplier but also a manufacturer known for its high-quality anatomical and forensic equipment. Their reputation is built on engineering excellence, innovative practices, and a steadfast commitment to enhancing laboratory results for their clientele. With a determination to evolve and grow, Mopec Group aims to create a more integrated and impactful future in the field of pathology solutions.

This strategic consolidation marks a significant chapter in Mopec's journey, one that is aimed at bolstering their position as a leader in pathology technology, while enhancing the capacity to provide exceptional care within the medical sector.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.